Praveg Comm - Praveg Share Price

889.00-6.10 (-0.68%)

BSE

Live
As On:
As On: 30 Aug, 2024, 03:01 PM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

STOCK SCORE

Unlock Scores

Add to Watchlist

OpenN.A.
HighN.A.
LowN.A.
Prev CloseN.A.
VolumeN.A.
VWAP(₹)N.A.

Praveg Comm share price insights

Employee & Interest Expense
Company has spent 2.61% of its operating revenues towards interest expenses and 17.47% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 706.4% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 706.4% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
Praveg Comm Share Price Update
Praveg Ltd. share price moved down by -0.68% from its previous close of Rs 895.10. Praveg Ltd. stock last traded price is 889.00
Share Price Value
Today/Current/Last -889.00
Previous Day -895.10

Share Price	Value
Today/Current/Last	-889.00
Previous Day	-895.10

Praveg Comm Share Price Returns

1 Day	-0.68%
1 Month	9.37%
3 Months	9.24%
1 Year	82.79%
3 Years	695.53%
5 Years	14766.22%

Key Metrics

PE Ratio(x)	181.99
EPS - TTM(₹)	4.88
MCap(₹ Cr.)	2,285.57
MCap Rank	68
PB Ratio(x)	8.03
Div Yield(%)	0.11
Face Value(₹)	10.00
52W High(₹)	1,300.00
52W Low(₹)	475.10
MCap/Sales	26.53
Beta(1 Month)	-0.09
BV/Share(₹)	111.45

Praveg Comm Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Praveg Comm News & Analysis

View all Praveg Comm Share News & Announcements

Praveg Comm Financials

Consolidated

Income (P&L)

	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Total Income	24.68	33.50	33.97	14.64	12.45
Total Income Growth (%)	-26.31	-1.40	132.07	17.62	-34.50
Total Expenses	22.02	25.38	24.54	12.43	10.75
Total Expenses Growth (%)	-13.21	3.39	97.50	15.65	-5.23
EBIT	2.66	8.12	9.43	2.21	1.70
EBIT Growth (%)	-67.24	-13.87	326.27	30.13	-77.81
Profit after Tax (PAT)	0.76	1.64	8.10	2.10	1.17
PAT Growth (%)	-53.46	-79.75	286.47	79.36	-77.41
EBIT Margin (%)	10.78	24.25	27.76	15.11	13.66
Net Profit Margin (%)	3.09	4.89	23.83	14.31	9.39
Basic EPS (₹)	0.30	0.73	3.56	0.98	0.53

	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Total Income	24.68	33.50	33.79	14.64	12.45
Total Income Growth (%)	-26.31	-0.88	130.85	17.62	-34.50
Total Expenses	22.02	25.48	24.37	12.42	10.75
Total Expenses Growth (%)	-13.57	4.55	96.21	15.59	-5.23
EBIT	2.66	8.02	9.42	2.22	1.70
EBIT Growth (%)	-66.81	-14.91	324.80	30.47	-77.81
Profit after Tax (PAT)	0.76	1.54	8.09	2.10	1.17
PAT Growth (%)	-50.30	-81.02	285.03	79.86	-77.41
EBIT Margin (%)	10.78	23.93	27.88	15.15	13.66
Net Profit Margin (%)	3.09	4.58	23.94	14.35	9.39
Basic EPS (₹)	0.30	0.68	3.55	0.98	0.53

	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	94.55	84.86	45.29	45.65	59.92
Total Revenue Growth (%)	11.42	87.36	-0.78	-23.81	-1.55
Total Expenses	75.48	46.34	28.71	31.38	54.69
Total Expenses Growth (%)	62.89	61.38	-8.51	-42.61	-3.77
Profit after Tax (PAT)	13.00	28.43	12.24	10.74	3.65
PAT Growth (%)	-54.28	132.26	13.98	194.24	33.78
Operating Profit Margin (%)	23.43	46.41	37.74	32.21	9.70
Net Profit Margin (%)	14.19	33.65	27.05	23.70	6.13
Basic EPS (₹)	5.78	14.78	6.62	5.83	1.98

	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	94.37	84.76	45.03	45.70	59.87
Total Revenue Growth (%)	11.34	88.23	-1.46	-23.68	0.03
Total Expenses	75.41	46.29	28.47	31.37	54.66
Total Expenses Growth (%)	62.89	62.62	-9.27	-42.60	0.01
Profit after Tax (PAT)	12.89	28.38	12.23	10.80	3.64
PAT Growth (%)	-54.57	132.10	13.23	196.31	-
Operating Profit Margin (%)	23.36	46.40	37.93	32.37	9.66
Net Profit Margin (%)	14.10	33.63	27.17	23.85	6.12
Basic EPS (₹)	5.73	14.75	6.61	5.86	1.97

All figures in Rs Cr, unless mentioned otherwise

Insights

Employee & Interest Expense
Company has spent 2.61% of its operating revenues towards interest expenses and 17.47% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

Balance Sheet

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	364.59	125.61	37.88	26.98	24.87
Total Assets Growth (%)	190.25	231.59	40.40	8.51	15.77
Total Liabilities	76.75	13.15	10.28	7.92	9.91
Total Liabilities Growth (%)	483.61	27.94	29.72	-20.07	2.26
Total Equity	287.84	112.46	27.60	19.06	14.95
Total Equity Growth (%)	155.94	307.43	44.84	27.46	26.88
Current Ratio (x)	12.43	4.93	2.57	3.87	2.42
Total Debt to Equity (x)	0.00	0.00	0.12	0.05	0.06
Contingent Liabilities	0.00	10.03	5.85	4.26	4.30

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	364.44	125.61	37.94	27.08	24.79
Total Assets Growth (%)	190.14	231.08	40.10	9.24	0.00
Total Liabilities	76.69	13.12	10.25	7.92	9.90
Total Liabilities Growth (%)	484.53	28.00	29.42	-20.00	0.01
Total Equity	287.76	112.49	27.69	19.16	14.89
Total Equity Growth (%)	155.81	306.25	44.52	28.68	0.00
Current Ratio (x)	13.27	4.99	2.57	3.87	2.41
Total Debt to Equity (x)	0.00	0.00	0.12	0.05	0.06
Contingent Liabilities	0.00	10.03	5.85	4.26	4.30

All figures in Rs Cr, unless mentioned otherwise

Cash Flows

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	17.04	25.27	6.61	15.20	5.89
Net Cash used in Investing Activities	-177.87	-72.60	-12.91	-0.49	-0.62
Net Cash flow from Financing Activities	220.33	52.06	-2.46	-8.34	-3.12
Net Cash Flow	59.50	4.73	-8.75	6.37	2.15
Closing Cash & Cash Equivalent	64.40	4.90	0.39	9.14	2.77
Closing Cash & Cash Equivalent Growth (%)	1,213.77	1,149.16	-95.71	229.97	345.42
Total Debt/ CFO (x)	0.00	0.02	0.50	0.06	0.16

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	17.30	25.21	6.60	14.19	2.56
Net Cash used in Investing Activities	-179.04	-72.61	-12.91	0.74	3.75
Net Cash flow from Financing Activities	220.34	52.06	-2.48	-8.34	-4.74
Net Cash Flow	58.60	4.66	-8.79	6.59	1.57
Closing Cash & Cash Equivalent	63.36	4.76	0.32	9.11	2.52
Closing Cash & Cash Equivalent Growth (%)	1,230.51	1,387.75	-96.49	261.25	0.00
Total Debt/ CFO (x)	0.00	0.02	0.50	0.06	0.37

All figures in Rs Cr, unless mentioned otherwise

Insights

Increase in Cash from Investing
Company has used Rs 177.87 cr for investing activities which is an YoY increase of 145.01%. (Source: Consolidated Financials)

Ratios

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	4.51	25.28	44.35	56.35	24.58
Return on Capital Employed (%)	6.08	34.55	57.67	67.45	35.88
Return on Assets (%)	3.56	22.63	32.31	39.80	14.67
Interest Coverage Ratio (x)	13.45	65.62	39.45	48.52	12.41
Asset Turnover Ratio (x)	0.37	1.03	1.40	1.75	2.57
Price to Earnings (x)	188.68	34.25	20.45	11.15	4.59
Price to Book (x)	8.44	8.66	9.07	6.28	1.13
EV/EBITDA (x)	72.39	21.00	12.81	6.85	2.18
EBITDA Margin (%)	35.09	53.62	43.66	35.83	11.32

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	4.48	25.22	44.16	56.36	24.47
Return on Capital Employed (%)	6.05	34.49	57.46	67.41	35.87
Return on Assets (%)	3.53	22.59	32.22	39.87	14.70
Interest Coverage Ratio (x)	13.41	65.58	39.43	48.78	12.44
Asset Turnover Ratio (x)	0.37	1.03	1.38	1.75	4.78
Price to Earnings (x)	188.68	34.36	20.49	11.09	4.59
Price to Book (x)	8.44	8.65	9.04	6.24	1.12
EV/EBITDA (x)	72.66	21.03	12.82	6.83	2.21
EBITDA Margin (%)	35.04	53.62	43.88	36.00	11.28

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Praveg Comm	181.99	7.96	4.51	6.08	3.56	27.16	23.43	14.19	5.78	12.43	0.00	0.00
Solara Active Pharma	-5.99	3.59	-60.76	-17.42	-24.13	-7.62	-14.98	-43.98	-157.62	0.64	1.07	9.18
SMS Pharma	50.18	5.33	9.29	12.75	4.81	7.91	12.62	6.93	5.89	1.61	0.52	5.59
IOL Chemicals	21.92	1.61	8.34	11.74	5.98	2.77	9.27	6.30	22.90	2.00	0.00	0.00
Amrutanjan Health Care	55.51	8.19	15.58	20.91	12.25	8.30	14.74	10.67	15.56	4.23	0.00	0.00

Annual Ratios (%)

Stock Performance

TABLE

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Praveg Comm Stock Performance	-0.72	2.07	11.43	7.17	85.07	700.54	0.00
Solara Active Pharma Stock Performance	-0.35	-2.20	15.49	63.15	90.00	-57.08	59.22
SMS Pharma Stock Performance	-1.02	10.37	21.56	59.95	158.25	99.56	621.56
IOL Chemicals Stock Performance	0.13	-5.12	3.75	21.28	6.19	-20.65	146.51
Amrutanjan Health Care Stock Performance	-0.90	7.82	9.49	17.33	34.22	12.52	186.46

All values in %

Insights

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 706.4% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 706.4% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)

Mutual Funds Ownership

MF Ownership as on 31 July 2024

Tata Retirement Savings Moderate Direct-G
Hybrid: Aggressive Hybrid
3.0
- 16.63
  Amount Invested (in Cr.)
- 0.76%
  % of AUM
- 0.00
  % Change (MoM basis)
Tata Retirement Savings Progressive Direct-G
Equity: Flexi Cap
3.0
- 15.91
  Amount Invested (in Cr.)
- 0.76%
  % of AUM
- 0.00
  % Change (MoM basis)
Tata Business Cycle Direct-G
Equity: Thematic
- 13.85
  Amount Invested (in Cr.)
- 0.5%
  % of AUM
- 0.00
  % Change (MoM basis)

View all Mutual Fund Schemes

Corporate Actions

Recent
Board Meeting
Quarterly Results
Aug 05, 2024
Final
10%
May 27, 2024
Board Meeting
Audited Results & Final Dividend
May 21, 2024

Board Meetings

Announced on	Meeting on
Aug 05, 2024	Aug 10, 2024
Quarterly Results
May 21, 2024	May 27, 2024
Audited Results & Final Dividend
Apr 01, 2024	Apr 04, 2024
Preferential issue of shares
Feb 05, 2024	Feb 13, 2024
Quarterly Results
Nov 02, 2023	Nov 09, 2023
Quarterly Results

Dividends
Announced on Ex-Date Dividend%
May 30, 2023 Sep 15, 2023 45%
May 24, 2022 Nov 21, 2022 40%
Jun 10, 2021 Jul 15, 2021 20%
Feb 01, 2021 Feb 15, 2021 20%
May 27, 2024 - 10%
Bonus
No Data Available
Splits
Announced on Ex-Date
Aug 21, 2001 -
Split: Old FV10.0| New FV:1.0
Rights
No Data Available
AGM/EGM Meetings
Announced on Meeting on
Dec 29, 2023 Jan 23, 2024
-
Aug 14, 2023 Sep 22, 2023
-
Jun 30, 2023 Aug 02, 2023
-
Jan 13, 2023 Feb 04, 2023
-
Oct 28, 2022 Nov 28, 2022
-

Announced on	Ex-Date	Dividend%
May 30, 2023	Sep 15, 2023	45%
May 24, 2022	Nov 21, 2022	40%
Jun 10, 2021	Jul 15, 2021	20%
Feb 01, 2021	Feb 15, 2021	20%
May 27, 2024	-	10%

Announced on	Ex-Date
Aug 21, 2001	-
Split: Old FV10.0\| New FV:1.0

Announced on	Meeting on
Dec 29, 2023	Jan 23, 2024
-
Aug 14, 2023	Sep 22, 2023
-
Jun 30, 2023	Aug 02, 2023
-
Jan 13, 2023	Feb 04, 2023
-
Oct 28, 2022	Nov 28, 2022
-

About

Praveg Ltd., incorporated in the year 1995, is a Small Cap company (having a market cap of Rs 2,311.65 Crore) operating in Pharmaceuticals sector.

Praveg Ltd. key Products/Revenue Segments include Sale of services and Other Operating Revenue for the year ending 31-Mar-2023.

For the quarter ended 30-06-2024, the company has reported a Consolidated Total Income of Rs 24.68 Crore, down 26.31 % from last quarter Total Income of Rs 33.50 Crore and up 98.34 % from last year same quarter Total Income of Rs 12.45 Crore. Company has reported net profit after tax of Rs .76 Crore in latest quarter.

The company’s top management includes Mr.Vishnukumar Patel, Mr.Paraskumar Patel, Ms.Bhumit Patel, Ms.Bijal Parikh, Mr.Ajit Panda, Mr.Jaladhi Shah, Mr.Keyoor Bakshi, Ms.Pooja Khakhi, Mr.Rajendrakumar Patel, Mr.Dharmendra Soni, Mr.Mukesh Chaudhary. Company has B K Patel & Co. as its auditors. As on 30-06-2024, the company has a total of 2.58 Crore shares outstanding.

About Praveg Comm

Praveg Ltd., incorporated in the year 1995, is a Small Cap company (having a market cap of Rs 2,311.65 Crore) operating in Pharmaceuticals sector. Praveg Ltd. key Products/Revenue Segments include Sale of services and Other Operating Revenue for the year ending 31-Mar-2023.For the quarter ended 30-06-2024, the company has reported a Consolidated Total Income of Rs 24.68 Crore, down 26.31 % from last quarter Total Income of Rs 33.50 Crore and up 98.34 % from last year same quarter Total Income of Rs 12.45 Crore. Company has reported net profit after tax of Rs .76 Crore in latest quarter.The company’s top management includes Mr.Vishnukumar Patel, Mr.Paraskumar Patel, Ms.Bhumit Patel, Ms.Bijal Parikh, Mr.Ajit Panda, Mr.Jaladhi Shah, Mr.Keyoor Bakshi, Ms.Pooja Khakhi, Mr.Rajendrakumar Patel, Mr.Dharmendra Soni, Mr.Mukesh Chaudhary. Company has B K Patel & Co. as its auditors. As on 30-06-2024, the company has a total of 2.58 Crore shares outstanding.

Industry

Pharma - Indian

Key Indices Listed On

BSE SmallCap, BSE Consumer Discretionary, BSE AllCap, BSE MidSmallCap

Address

214, Athena Avenue,Behind Jaguar Showroom,S. G. Highway, Gota,Ahmedabad, Gujarat - 382481

Contact

info@praveg.com

http://www.praveg.com

Executive Leadership

Vishnukumar Patel

Chairman & Non-Exe.Director

Paraskumar Patel

Managing Director

Bhumit Patel

Executive Director

Bijal Parikh

Executive Director

Auditors

B K Patel & Co.

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

Praveg Comm - Praveg Share Price

Praveg Comm share price insights

Praveg Comm Share Price Returns

Key Metrics

Praveg Comm Share Recommendations

Praveg Comm News & Analysis

Praveg Comm Financials

Income (P&L)

Balance Sheet

Cash Flows

Ratios

Peer Comparison

Ratio Performance

Stock Performance

Mutual Funds Ownership

Tata Retirement Savings Moderate Direct-G

Hybrid: Aggressive Hybrid

Tata Retirement Savings Progressive Direct-G

Equity: Flexi Cap

Tata Business Cycle Direct-G

Equity: Thematic

Corporate Actions

Recent

Board Meetings

Dividends

Bonus

Splits

Rights

AGM/EGM Meetings

About

About Praveg Comm

Executive Leadership

Auditors

Equity Quick Links

More from Markets

Trending in Markets

Most Recent

Most Read

Browse Companies

Trending Now

Popular Categories

Hot on Web

In Case you missed it

More from our network

Latest News

Download ET APP

Follow us on

become a member